NCT04425577

Brief Summary

To determine if uterine cavity length on transabdominal pelvic ultrasound corresponds to uterine cavity length at time of IUD insertion. If transabdominal pelvic ultrasound is validated as a tool for measuring uterine cavity length, it can be used to guide physicians and subsequently patients in IUD insertion planning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 8, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

February 28, 2023

Status Verified

February 1, 2023

Enrollment Period

3 years

First QC Date

June 8, 2020

Last Update Submit

February 24, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quantify Temporal Relationship between Transabdominal Ultrasound and Uterine Sound

    To determine if uterine cavity length on ultrasound corresponds to uterine cavity length at time of IUD insertion

    Within 60 days of enrollment

Study Arms (1)

Transabdominal Ultrasound

OTHER

All patients enrolled will undergo a transabdominal ultrasound at a specified time point as outlined in the protocol.

Diagnostic Test: Transabdominal Ultrasound

Interventions

Transabdominal Ultrasound

Transabdominal Ultrasound

Eligibility Criteria

Age12 Years - 22 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis is for intrauterine device placement so all participants must have a uterus.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • IUD inserted between 12/1/19 and 12/1/20
  • Received a transabdominal US of the uterus

You may not qualify if:

  • US never performed
  • Mullerian anomaly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Mercy Hospital

Kansas City, Missouri, 64108, United States

Location

Related Publications (4)

  • Usinger KM, Gola SB, Weis M, Smaldone A. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review. J Pediatr Adolesc Gynecol. 2016 Dec;29(6):659-667. doi: 10.1016/j.jpag.2016.06.007. Epub 2016 Jul 4.

    PMID: 27386754BACKGROUND
  • Savasi I, Jayasinghe K, Moore P, Jayasinghe Y, Grover SR. Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities. J Pediatr Adolesc Gynecol. 2014 Feb;27(1):25-8. doi: 10.1016/j.jpag.2013.08.010. Epub 2013 Dec 4.

    PMID: 24315712BACKGROUND
  • Dizon CD, Allen LM, Ornstein MP. Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the Hospital for Sick Children, Toronto. J Pediatr Adolesc Gynecol. 2005 Jun;18(3):157-62. doi: 10.1016/j.jpag.2005.03.002.

    PMID: 15970247BACKGROUND
  • Lacy J. Clinic opinions regarding IUCD use in adolescents. J Pediatr Adolesc Gynecol. 2006 Aug;19(4):301-3. doi: 10.1016/j.jpag.2006.05.013. No abstract available.

    PMID: 16873036BACKGROUND

MeSH Terms

Conditions

DysmenorrheaMenorrhagia

Condition Hierarchy (Ancestors)

Menstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsPelvic PainPainNeurologic ManifestationsSigns and SymptomsUterine HemorrhageUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesHemorrhage

Study Officials

  • Ashli Lawson, MD

    Children's Mercy Hospital Kansas City

    PRINCIPAL INVESTIGATOR
  • Julie Strickland, MD

    Children's Mercy Hospital Kansas City

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Patients who are clinically undergoing intrauterine device (IUD) placement will be consecutively studied
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician

Study Record Dates

First Submitted

June 8, 2020

First Posted

June 11, 2020

Study Start

January 6, 2020

Primary Completion

December 31, 2022

Study Completion

February 1, 2023

Last Updated

February 28, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations